Carta | Latest News & Updates - Nov 11, 2024 Release

Carta has updated its pricing plans by removing share plan management from the Build plan, 50+ HR integrations from the Grow plan, and expense reporting from the Scale plan...


Brought to you by RivalSense - an AI tool for monitoring any company.

RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡


Carta

🌎 carta.com

Carta is an ownership and equity management platform trusted by thousands of founders, investors, and employees. They provide solutions for cap table management, equity management, valuations, and equity plans. Trusted by over 40,000 companies and 2 million users globally, Carta aims to unlock the power of equity ownership for more people.


Carta - Latest News and Updates

  • Carta has updated its pricing plans by removing share plan management from the Build plan, 50+ HR integrations from the Grow plan, and expense reporting from the Scale plan.
  • Carta's Q3 2024 report indicates a new normal in the venture market with upward trends in later-stage deal activity and M&As following the pandemic bull run.
  • Henry Ward, CEO of Carta, advises against starting a captable company, emphasizing that the market is too small and unsustainable for venture scale growth.
  • Carta's latest pre-seed report reveals a rise in discount-only SAFEs, benefiting hardtech founders.
  • Carta's Q3 2024 State of Pre-Seed report reveals that SAFEs are the default instrument for pre-seed funding across major US metro areas, with 58% using valuation cap only and a median post-money valuation cap of $10M for a $1M raise.
  • Carta is hosting a lunch and learn event focused on money and motherhood at their NY office with WVC:E next week.
  • Jared Thomas, former Head of Product at Carta, announced his move to Flex on November 9.
  • Carta's team discussed strategies for balancing executive buy-in and market competitiveness using their total compensation solution.
  • Carta and Peter J. Walker report that Austin ranks 6th in early-stage funding overall, with Healthtech at 4th and Biotech at 8th.

Sign up to receive regular updates


If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.